Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
2 of 6 columns
Comparison
| Attribute | Alzamend Neuro, Inc.12.5remove | Serina Therapeutics, Inc.13.4remove |
|---|---|---|
| Signal scores | ||
| Radar composite | 12.5 | 13.4 |
| IPO signal score | 25.1 | 26.9 |
| Tokenization signal score | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 |
| Momentum | ACCELERATING+11.1 | ACCELERATING+12.4 |
| Company | ||
| Stage | filed | filed |
| Sector | not on record | not on record |
| Headquarters | ATLANTA | HUNTSVILLE |
| Founded | not on record | not on record |
| Employees | not on record | not on record |
| Capital | ||
| Latest valuation | not on record | not on record |
| Total funding | not on record | not on record |
| Latest round | not on record | not on record |
| Investors on record | 0 | 0 |
| Evidence | ||
| Institutional relationships | 0 | 0 |
| Active signals | 27 | 40 |
| Confidence | 69% | 71% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.